financetom
Business
financetom
/
Business
/
Marriott cuts 2024 revenue forecast on weakening domestic tourism in the US
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Marriott cuts 2024 revenue forecast on weakening domestic tourism in the US
Jul 31, 2024 4:46 AM

(Reuters) -Hotel operator Marriott International ( MAR ) lowered its forecast for 2024 room revenue growth on Wednesday, as the domestic travel industry in the U.S. continues to perform poorly.

Shares of the company were down 4.7% before the bell.

Marriott ( MAR ) expects revenue per available room (RevPAR) to grow between 3% and 4% this year, compared to the 3% to 5% growth it had previously forecast.

Domestic travel in the U.S. has been weak since the start of the year as more tourists are choosing to travel internationally to destinations in Asia, Latin America and Europe.

The company said it was also impacted by a weaker operating environment in Greater China.

Total revenue for the quarter through June 30 was $6.44 billion, up about 6% from a year earlier.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BriaCell Adds Three Cancer Centres to Phase 3 Study, Works With MSK Accelerator to Advance Bria-OTS+
BriaCell Adds Three Cancer Centres to Phase 3 Study, Works With MSK Accelerator to Advance Bria-OTS+
Oct 21, 2025
08:16 AM EDT, 10/21/2025 (MT Newswires) -- BriaCell Therapeutics ( BCTX ) said Tuesday it is adding three cancer centers to its Phase 3 clinical study, and expects to report top-line data as early as the first half of next year. The three centres are Dartmouth Cancer Center, Cedars-Sinai Medical Center, and Winship Cancer Institute of Emory University. The Phase...
Arrowhead Pharmaceuticals Closes Licensing Deal With Novartis
Arrowhead Pharmaceuticals Closes Licensing Deal With Novartis
Oct 21, 2025
08:19 AM EDT, 10/21/2025 (MT Newswires) -- Arrowhead Pharmaceuticals ( ARWR ) said Tuesday it has closed a global licensing and collaboration agreement with Novartis ( NVS ) for ARO-SNCA preclinical RNA interference therapy to potentially treat patients with Parkinson's disease and other synucleinopathies. Under the deal, Arrowhead said it will receive a $200 million upfront payment and would be...
Market Chatter: Apollo, KKR, Carlyle Tapped to Discuss Funding for $150 Billion US Army Overhaul
Market Chatter: Apollo, KKR, Carlyle Tapped to Discuss Funding for $150 Billion US Army Overhaul
Oct 21, 2025
08:18 AM EDT, 10/21/2025 (MT Newswires) -- Apollo Global Management ( APO ) , KKR (KKR) and Carlyle Group ( CG ) , alongside Cerberus, discussed pitching large-scale projects to help finance a $150 billion US Army infrastructure program, the Financial Times reported Tuesday, citing an interview with Army Secretary Daniel Driscoll. About 15 buyout firms met with Driscoll and...
Anfield Completes Confirmation Drill Program at JD-7 Mine of Paradox Mine Complex
Anfield Completes Confirmation Drill Program at JD-7 Mine of Paradox Mine Complex
Oct 21, 2025
08:17 AM EDT, 10/21/2025 (MT Newswires) -- Anfield Energy ( AEC ) Tuesday said it has completed a confirmation drill program at its JD-7 mine, on elf the five mines that make up its Paradox mine complex. The drill results will be incorporated into a new uranium and vanadium resource report in the first quarter of 2026. Highlights of the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved